Oxford-AstraZeneca: EU regulator says 'no indication' vaccine linked to blood clots
The EU's medicines regulator reassures states after several countries suspended use of the vaccine.
Stay updated with breaking news from Phil Bryan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The EU's medicines regulator reassures states after several countries suspended use of the vaccine.
Officials in Denmark, Norway and Iceland halted use as a "cautionary decision." Four other countries — Estonia, Lithuania, Luxembourg and Latvia — have stopped inoculations from the batch while investigations continue.
A decision by Denmark to temporarily halt use of the Oxford/AstraZeneca vaccine is a "precautionary measure" and people should continue to get their jab, the UK regulator has said.
Oli Scarff/AFP via Getty Images Denmark and Norway suspended the use of AstraZeneca's COVID-19 shot Thursday as a "precautionary measure". The Danish Health authorities cited concerns about blood clots in people that had received the shot. Data suggests that the risk of clots is no greater than in the population at large. Denmark, Norway, and Iceland suspended their roll out of AstraZeneca and the University of Oxford's COVID-19 vaccine as a "precautionary" step Thursday, citing concerns about blood clots in people who had received the shot. One person in Denmark...
DENMARK has halted the rollout of the AstraZeneca/Oxford vaccine following 'severe cases of blood clots in people' who had received the jab. 'It has not been confirmed that the report of a blood clot, in Denmark, was caused by the COVID-19 Vaccine AstraZeneca,' says Dr Phil Bryan, MHRA, Vaccine Safety Lead.